logo

Client Login Franchisee Login

Company Information

Home | Market | Company Info | Overview

Get Quotes

Market Nav

INDUSTRY NEWS

Cohance Lifesciences Ltd.

BSE

Jun 03, 11:46
1021.25
-2.20 ( -0.21%)
Volume 10922
Prev. Close 1023.45
Open Price 1022.40
Today's Low / High
1016.05
     
1041.35
Bid Price(Qty.) 1018.60 (2)
Offer Pr.(Qty.) 1019.60 (7)
52 Wk Low / High
597.00
     
1359.00

NSE

Jun 03, 11:34
1019.00
-3.50 ( -0.34%)
Volume 44469
Prev. Close 1022.50
Open Price 1034.70
Today's Low / High
1016.80
     
1045.00
Bid Price(Qty.) 1018.40 (16)
Offer Pr.(Qty.) 1019.50 (76)
52 Wk Low / High
598.00
     
1360.00
You can view the latest news of the Industry.
ISIN No INE03QK01018 Market Cap. ( ₹ in Cr. ) 25940.17 P/BV 13.11 Book Value ( ₹ ) 77.71
BSE Code 543064 52 Week High/Low ( ₹ ) 1360/598 FV/ML 1/1 P/E(X) 96.84
NSE Code COHANCEEQ Book Closure 09/08/2024 EPS ( ₹ ) 10.52 Div Yield (%) 0.00
Date and TimeHeadlines
02/06/2025 15:12 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcr...
02/06/2025 15:11 Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates
30/05/2025 14:17 Cohance Lifesciences - Copy of Newspaper Publication
29/05/2025 13:38 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Credit Rating
29/05/2025 13:37 Cohance Lifesciences - Credit Rating
28/05/2025 20:37 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Me...
28/05/2025 20:32 Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates
28/05/2025 19:55 Cohance Lifesciences has submitted to BSE the Shareholding Pattern for the Period En...
28/05/2025 18:49 Cohance Lifesciences - Financial Results For Period Ended March 31, 2025
28/05/2025 18:03 Cohance Lifesciences Q4 net profit down 17.01% at Rs 44.34 cr
28/05/2025 17:58 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media...
28/05/2025 17:57 Cohance Lifesciences - Investor Presentation
28/05/2025 17:55 Cohance Lifesciences - Press Release
28/05/2025 17:55 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Investor Presentation
28/05/2025 17:37 Cohance Lifesciences - Outcome of Board Meeting
28/05/2025 17:35 Cohance Lifesciences - Board Meeting Outcome for Outcome Of Board Meeting
26/05/2025 13:07 Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Me...
26/05/2025 13:06 Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates
26/05/2025 10:19 Cohance Lifesciences gets USFDA EIR for Telangana Unit; Tagged VAI
25/05/2025 21:51 Cohance Lifesciences - General Announcement
25/05/2025 21:48 Cohance Lifesciences - General Updates
19/05/2025 12:50 Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates
13/05/2025 19:59 Suven Pharmaceutical - Change In The Name And Trading Symbol
13/05/2025 19:57 Suven Pharmaceutical - General Updates
13/05/2025 17:54 Suven Pharmaceutical - Name and Symbol Change
12/05/2025 11:02 Suven Pharmaceutical - Disclosure under SEBI Takeover Regulations
12/05/2025 10:12 Suven Pharmaceutical - Disclosures of reasons for encumbrance by promoter of listed ...
09/05/2025 09:00 Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Allotment
09/05/2025 08:59 Suven Pharmaceutical - General Updates
08/05/2025 09:15 Suven Pharma rebrands as Cohance Lifesciences to reflect global CDMO vision

TRADEWELL SECURITIES LIMITED
CORPORATE MEMBER OF BOMBAY STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID : 3187  |  NATIONAL STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID: 12835>  |  MULTI COMMODITY EXCHANGE OF INDIA LTD  |  MEMBER ID: 56265
SEGMENTS: BSE CASH  |  BSE STAR MF  |  NSE CASH  |  NSE FO  |  NSE CD  |  NSE MF
SEBI REGN NO. INZ000171936
AMFI ARN CODE: 111875
CDSL DP ID NO. : 12052700 DP SEBI REG.NO.IN-DP-CDSL-432-2007
NSE | BSE | RBI | SEBI | CDSL | MCX | AMFI | SCORES

ATTENTION INVESTORS "Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Copyright © 2015 Tradewell Securities Limited. All rights reserved.

Designed, developed and content provided by dion

SMS Registration

Submit Clear

Mobile Trading

Segment

Submit Clear

logo

Submit Clear

Investors Grievances

igtsl@tradewellmail.com

Invest By QFI

QFI's Can now invest in Indian Capital Markets Through Tradewell Securities ltd -
For details Contact
Mr K.Brahmaiah - 9246399440/040-23541258.

CLIENT LOGIN

NOTES:

FRANCHISEE LOGIN

NOTES:

INTERNET TRADING

NOTES: